Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
View All Vacancies Engineering Location: UK Other Closing Date: Friday 16 August 2024 Reference: ENG1776 Project description: The primary challenge of access to clean and affordable energy will
-
View All Vacancies Veterinary Medicine & Science Location: UK Other Closing Date: Thursday 23 May 2024 Reference: MED2009 Principal supervisor: Professor Catrin Rutland Other supervisors
-
BBSRC strategic Longer and Larger project, GlycoWeb . The team includes research groups from The University of Nottingham, Liverpool University, Manchester University, and the Francis Crick Institute
-
View All Vacancies Nottingham University Business School Location: UK Other Closing Date: Wednesday 12 June 2024 Reference: SOC581 Midlands Graduate School Doctoral Training Partnership
-
Midlands Graduate School Doctoral Training Partnership ESRC DTP Strategic Joint Studentship University of Nottingham and University of Birmingham The Midlands Graduate School is an accredited
-
; Midlands Graduate School Doctoral Training Partnership | Nottingham, England | United Kingdom | 23 days ago
ESRC DTP Strategic Joint Studentship University of Nottingham and University of Birmingham The Midlands Graduate School is an accredited Economic and Social Research Council (ESRC) Doctoral Training
-
population-based cohorts with liver disease, including test results, patient-level variables, and outcomes during follow-up. Collaboration between the University of Nottingham (UK) and Aarhus University
-
Rolls-Royce University Technology Centre (UTC) in Manufacturing and On-Wing Technology, The University of Nottingham. Applicants are invited to undertake a 3-year PhD programme in partnership with
-
to large longitudinal population-based cohorts with liver disease, including test results, patient-level variables, and outcomes during follow-up. Collaboration between the University of Nottingham (UK) and
-
the field of Geroscience. Based at the University of Nottingham Medical School at Derby (UNMSD), this PhD is focussed on exploring the impact of an already-licensed mechanistic target of rapamycin (mTOR